Urinary retention

Data Suggest That Men Should Resolve to Address Their BPH Symptoms in 2019

Retrieved on: 
Wednesday, January 16, 2019
Women, Surgery, Health, Medical devices, Research, Consumer, Medical Supplies, Science, MEN, RTT, Anatomy, Andrology, Benign prostatic hyperplasia, Men's Health, Medicine, Prostate cancer, Prostate, BPH, Urinary retention, Alpha-1 blocker

BPH, also known as enlarged prostate, is non-cancerous enlargement of the prostate that occurs as men age.

Key Points: 
  • BPH, also known as enlarged prostate, is non-cancerous enlargement of the prostate that occurs as men age.
  • The condition affects over 40 million men in the United States alone, with more than 40 percent of men over 50 and 80 percent of men over 70 having BPH.
  • The results demonstrated that many of the surveyed men and women are not aware of BPH treatment options beyond medication.
  • Unfortunately, men sometimes avoid talking with their doctor about symptoms because of the perceived side effects of BPH treatment options.

Spinal Singularity Awarded Phase II SBIR Grant From NIH

Retrieved on: 
Thursday, October 4, 2018
Medicine, Catheters, Clinical medicine, RTT, Intermittent catheterisation, Urinary retention, Urinary tract infection, Urinary system, Urinary catheterization

Spinal Singularity has been developing the C2P, an innovative, smart catheter system designed for adult males with Chronic Urinary Retention and/or Neurogenic Lower Urinary Tract Dysfunction (NLUTD).Funds granted to Spinal Singularity will be utilized to conduct clinical studies of the C2P at the following clinical research sites.

Key Points: 
  • Spinal Singularity has been developing the C2P, an innovative, smart catheter system designed for adult males with Chronic Urinary Retention and/or Neurogenic Lower Urinary Tract Dysfunction (NLUTD).Funds granted to Spinal Singularity will be utilized to conduct clinical studies of the C2P at the following clinical research sites.
  • Rancho Los Amigos National Rehabilitation Center Downey, CA - Drs.
  • Spinal Singularity is a seed stage, venture-backed, medical device company developing products to improve the lives of patients with spinal injury.The company has developed the C2P, the first fully internal, smart catheter system for adult males with Urinary Retention.One C2P may replace up to 200 disposable intermittent catheters.
  • The Connected Catheter is currently an INVESTIGATIONAL DEVICE ONLY and limited by federal (or United States) law to investigational use.

Spinal Singularity Awarded Phase II SBIR Grant From NIH

Retrieved on: 
Thursday, October 4, 2018
Medicine, Catheters, Clinical medicine, RTT, Intermittent catheterisation, Urinary retention, Urinary tract infection, Urinary system, Urinary catheterization

Spinal Singularity has been developing the C2P, an innovative, smart catheter system designed for adult males with Chronic Urinary Retention and/or Neurogenic Lower Urinary Tract Dysfunction (NLUTD).Funds granted to Spinal Singularity will be utilized to conduct clinical studies of the C2P at the following clinical research sites.

Key Points: 
  • Spinal Singularity has been developing the C2P, an innovative, smart catheter system designed for adult males with Chronic Urinary Retention and/or Neurogenic Lower Urinary Tract Dysfunction (NLUTD).Funds granted to Spinal Singularity will be utilized to conduct clinical studies of the C2P at the following clinical research sites.
  • Rancho Los Amigos National Rehabilitation Center Downey, CA - Drs.
  • Spinal Singularity is a seed stage, venture-backed, medical device company developing products to improve the lives of patients with spinal injury.The company has developed the C2P, the first fully internal, smart catheter system for adult males with Urinary Retention.One C2P may replace up to 200 disposable intermittent catheters.
  • The Connected Catheter is currently an INVESTIGATIONAL DEVICE ONLY and limited by federal (or United States) law to investigational use.

Spinal Singularity Awarded Phase II SBIR Grant From NIH

Retrieved on: 
Thursday, October 4, 2018
Medicine, Catheters, Clinical medicine, RTT, Intermittent catheterisation, Urinary retention, Urinary tract infection, Urinary system, Urinary catheterization

Spinal Singularity has been developing the C2P, an innovative, smart catheter system designed for adult males with Chronic Urinary Retention and/or Neurogenic Lower Urinary Tract Dysfunction (NLUTD).Funds granted to Spinal Singularity will be utilized to conduct clinical studies of the C2P at the following clinical research sites.

Key Points: 
  • Spinal Singularity has been developing the C2P, an innovative, smart catheter system designed for adult males with Chronic Urinary Retention and/or Neurogenic Lower Urinary Tract Dysfunction (NLUTD).Funds granted to Spinal Singularity will be utilized to conduct clinical studies of the C2P at the following clinical research sites.
  • Rancho Los Amigos National Rehabilitation Center Downey, CA - Drs.
  • Spinal Singularity is a seed stage, venture-backed, medical device company developing products to improve the lives of patients with spinal injury.The company has developed the C2P, the first fully internal, smart catheter system for adult males with Urinary Retention.One C2P may replace up to 200 disposable intermittent catheters.
  • The Connected Catheter is currently an INVESTIGATIONAL DEVICE ONLY and limited by federal (or United States) law to investigational use.